The one Canadian cannabis player hitting it out of the park remains Aphria (APHA). Amazingly, the stock trades below $4 while posting FQ3 results that smashed analyst estimates. My bullish investment thesis was bolstered by the quarterly results despite the company pulling their guidance for the rest of the year due to some uncertainties surrounding COVID-19.
Image Source: Broken Coast website
Unrealistic Target
For FQ3, Aphria generated net revenues of C$144.4 million, up from C$120.6 million in the prior quarter. The company even smashed analyst consensus of C$130.8 million by a whopping C$13.5